Status:
TERMINATED
Investigation of Efficacy and Outcome of a New Medical Device for Treatment of Migraine
Lead Sponsor:
Karolinska University Hospital
Conditions:
Migraine
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of a novel therapy for treatment of migraine, pain reduction and relief of associated symptoms during ongoing migraine attacks, and presence of a ...
Eligibility Criteria
Inclusion
- Female or male subjects, in otherwise good health, 20 to 55 years of age
- Subjects who meet the ICHD-2 (2nd Edition of The International Headache Classification) criteria for migraine headache
- Subjects with a minimum of 1 migraine attack per month
- Attack duration of 4 to 72 hours
- Normal attack intensity of at least 4 on a 0-10 VAS-scale
Exclusion
- Completed heart surgery
- Cardiovascular diseases
- Vascular damages on neck vessels
- Diseases other than migraine of the CNS
- Severe disease of vital body organs
- Severe psychiatric disorders
- More than 6 migraine attacks per month
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01488110
Start Date
January 1 2012
Last Update
June 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital, Huddinge
Stockholm, Sweden, 14186